Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-alpha-phellandrene | increases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of SERTAD3 mRNA | CTD | PMID:25075043 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SERTAD3 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Sertad3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SERTAD3 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Sertad3 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SERTAD3 mRNA | CTD | PMID:22206623 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Sertad3 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sertad3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SERTAD3 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Sertad3 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SERTAD3 mRNA | CTD | PMID:25975270 | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-palmitoylglycerol | increases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of SERTAD3 mRNA | CTD | PMID:37199045 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SERTAD3 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Sertad3 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of SERTAD3 exon | CTD | PMID:33297965 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SERTAD3 mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SERTAD3 mRNA | CTD | PMID:28959563 | acrylamide | increases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of SERTAD3 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of SERTAD3 mRNA | CTD | PMID:33354967 | all-trans-retinoic acid | increases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SERTAD3 mRNA | CTD | PMID:33167477 | alpha-phellandrene | increases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of SERTAD3 mRNA | CTD | PMID:25075043 | amiodarone | increases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | Amiodarone results in increased expression of SERTAD3 mRNA | CTD | PMID:19774075 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of SERTAD3 mRNA | CTD | PMID:30779732 | arsenite(3-) | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to SERTAD3 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | decreases methylation | ISO | SERTAD3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of SERTAD3 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | SERTAD3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SERTAD3 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | Sertad3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of SERTAD3 3' UTR and Benzo(a)pyrene results in increased methylation of SERTAD3 exon | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SERTAD3 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SERTAD3 mRNA | CTD | PMID:32145629 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of SERTAD3 mRNA | CTD | PMID:31129395 | bisphenol F | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SERTAD3 mRNA | CTD | PMID:28628672 | CGP 52608 | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SERTAD3 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SERTAD3 mRNA | CTD | PMID:37019170 | chromium(6+) | decreases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | chromium hexavalent ion results in decreased expression of SERTAD3 mRNA | CTD | PMID:30690063 | cisplatin | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | Cisplatin promotes the reaction [jinfukang results in decreased expression of SERTAD3 mRNA] and jinfukang promotes the reaction [Cisplatin results in decreased expression of SERTAD3 mRNA] | CTD | PMID:27392435 | cisplatin | decreases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SERTAD3 mRNA | CTD | PMID:27392435 | copper(II) sulfate | increases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SERTAD3 mRNA | CTD | PMID:19549813 | dexamethasone | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SERTAD3 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of SERTAD3 mRNA | CTD | PMID:21266533 | erythromycin estolate | increases expression | EXP | | 6480464 | Erythromycin Estolate results in increased expression of SERTAD3 mRNA | CTD | PMID:24412560 | folic acid | multiple interactions | ISO | Sertad3 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SERTAD3 mRNA | CTD | PMID:22206623 | hydrogen cyanide | decreases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Hydrogen Cyanide results in decreased expression of SERTAD3 mRNA | CTD | PMID:33914522 | indometacin | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SERTAD3 mRNA | CTD | PMID:28628672 | leflunomide | decreases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of SERTAD3 mRNA | CTD | PMID:28988120 | methidathion | increases expression | ISO | Sertad3 (Mus musculus) | 6480464 | methidathion results in increased expression of SERTAD3 mRNA | CTD | PMID:34813904 | paracetamol | increases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of SERTAD3 mRNA | CTD | PMID:22230336 | PCB138 | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:23829299 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Sertad3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SERTAD3 mRNA | CTD | PMID:36331819 | pirinixic acid | multiple interactions | ISO | Sertad3 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SERTAD3 mRNA | CTD | PMID:19710929 | pirinixic acid | decreases expression | ISO | Sertad3 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of SERTAD3 mRNA | CTD | PMID:23811191 | potassium chromate | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SERTAD3 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SERTAD3 mRNA | CTD | PMID:22079256 and PMID:22714537 | potassium cyanide | decreases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Potassium Cyanide results in decreased expression of SERTAD3 mRNA | CTD | PMID:33914522 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of SERTAD3 mRNA | CTD | PMID:28903501 | silver atom | decreases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Silver results in decreased expression of SERTAD3 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Silver results in decreased expression of SERTAD3 mRNA | CTD | PMID:27131904 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SERTAD3 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Sertad3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SERTAD3 mRNA | CTD | PMID:27760801 | titanium dioxide | decreases expression | ISO | Sertad3 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SERTAD3 mRNA | CTD | PMID:29264374 | tributylstannane | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of SERTAD3 mRNA | CTD | PMID:31129395 | tungsten | increases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Tungsten results in increased expression of SERTAD3 mRNA | CTD | PMID:30912803 | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of SERTAD3 mRNA | CTD | PMID:24136188 | valproic acid | increases expression | ISO | Sertad3 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of SERTAD3 mRNA | CTD | PMID:15799026 | vincristine | decreases expression | ISO | SERTAD3 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of SERTAD3 mRNA | CTD | PMID:23649840 | zinc atom | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SERTAD3 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | SERTAD3 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SERTAD3 mRNA | CTD | PMID:18593933 | |